Maria Eugenia Sarasquete

Maria Eugenia Sarasquete

UNVERIFIED PROFILE

Are you Maria Eugenia Sarasquete?   Register this Author

Register author
Maria Eugenia Sarasquete

Maria Eugenia Sarasquete

Publications by authors named "Maria Eugenia Sarasquete"

Are you Maria Eugenia Sarasquete?   Register this Author

32Publications

1834Reads

45Profile Views

Exportin-1 E571K mutation is a common finding in patients with classical Hodgkin lymphoma.

Hematol Oncol 2019 Apr 8;37(2):215-218. Epub 2019 Jan 8.

Centro de Investigación del Cáncer de Salamanca; Servicio de Hematología, Hospital Universitario de Salamanca; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/hon.2570
Publisher Site
http://dx.doi.org/10.1002/hon.2570DOI Listing
April 2019

A safety profile of medications used to treat Waldenström's macroglobulinemia.

Expert Opin Drug Saf 2018 06 6;17(6):609-621. Epub 2018 Jun 6.

a Servicio de Hematología, Hospital Universitario de Salamanca , Instituto de Investigación Biomédica de Salamanca (IBSAL), Centro de Investigación del Cáncer de Salamanca, CIBERONC , Salamanca , Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/14740338.2018.1477936DOI Listing
June 2018

Different tools for the diagnosis and molecular follow-up of leukemias and lymphomas.

Med Clin (Barc) 2018 03 20;150(5):202-203. Epub 2017 Nov 20.

Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca, España. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.medcli.2017.10.012DOI Listing
March 2018

Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors.

Oncotarget 2017 Dec 21;8(64):107685-107700. Epub 2017 Nov 21.

Cytometry Service-NUCLEUS, Cancer Research Center, IBMCC-CSIC/USAL, Department of Medicine, University of Salamanca, Institute of Biomedical Research of Salamanca, Biomedical Research Networking Centre Consortium-CIBER-CIBERONC, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.18632/oncotarget.22591DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5746100PMC
December 2017

Genomic analysis of high-risk smoldering multiple myeloma.

Haematologica 2012 Sep 13;97(9):1439-43. Epub 2012 Feb 13.

Servicio de Hematología del Hospital Universitario de Salamanca y Centro de Investigación del Cáncer-IBMCC (USAl-CIC), Universidad de Salamanca, Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3324/haematol.2011.060780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3436247PMC
September 2012

Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.

Br J Haematol 2006 Oct 25;135(1):43-51. Epub 2006 Aug 25.

Centro de Investigación del Cáncer, Servicio General de Citometría and Departamento de Medicina, Universidad de Salamanca, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2141.2006.06265.xDOI Listing
October 2006

Minimal residual disease monitoring in multiple myeloma: a comparison between allelic-specific oligonucleotide real-time quantitative polymerase chain reaction and flow cytometry.

Haematologica 2005 Oct;90(10):1365-72

Grupo Español de Mieloma (GEM-PETHEMA), Red Española de Mieloma (G03/136), Servicio de Hematología, Hospital Universitario de Salamanca, Centro de Investigación del Cáncer (CIC), Universidad de Salamanca, Spain.

View Article

Download full-text PDF

Source
October 2005